Literature DB >> 27766647

The effect of microenvironmental factors on the development of myeloma cells.

Ágnes Márk1, Gergely Varga2, Botond Timár1, Csilla Kriston1, Orsolya Szabó1, Linda Deák1, András Matolcsy1, Gábor Barna1.   

Abstract

Multiple myeloma (MM) is a clonal B-cell malignancy characterized by the accumulation of monoclonal plasma cells (PCs) in the bone marrow and other tissues. Although there are several new therapies, MM remains fatal. The interaction between MM cells and the bone marrow microenvironment promotes drug resistance and cancer cells survival. In our present work, we compared the antigen expression pattern of normal and pathological PCs and investigated the possible connections between various surface receptors, adhesion molecules, and recurrent genetic aberrations. We showed that the expression of CD29, CD27, and CD81 is lower in MM cells than in normal PCs. We found correlation of chromosome 11 hyperdiploidity and the decrease of CD27 expression. We demonstrated that MM cells with CD20 positivity also have CD28 expression. Multiple myeloma patients with active CD29 showed better response to treatment. Our results suggest that these changes may result in an alteration of the interaction between stromal cell and MM cell facilitating cell survival and the development of a more aggressive and resistant phenotype.
Copyright © 2016 John Wiley & Sons, Ltd.

Entities:  

Keywords:  CD20; CD27; CD29; CD81; multiplex myeloma

Mesh:

Year:  2016        PMID: 27766647     DOI: 10.1002/hon.2354

Source DB:  PubMed          Journal:  Hematol Oncol        ISSN: 0278-0232            Impact factor:   5.271


  2 in total

1.  Biomimetic 3D Environment Based on Microgels as a Model for the Generation of Drug Resistance in Multiple Myeloma.

Authors:  Juan Carlos Marín-Payá; Blanca Díaz-Benito; Luis Amaro Martins; Sandra Clara Trujillo; Lourdes Cordón; Senentxu Lanceros-Méndez; Gloria Gallego Ferrer; Amparo Sempere; José Luis Gómez Ribelles
Journal:  Materials (Basel)       Date:  2021-11-23       Impact factor: 3.623

2.  Next generation flow for minimally-invasive blood characterization of MGUS and multiple myeloma at diagnosis based on circulating tumor plasma cells (CTPC).

Authors:  L Sanoja-Flores; J Flores-Montero; J J Garcés; B Paiva; N Puig; A García-Mateo; O García-Sánchez; A Corral-Mateos; L Burgos; E Blanco; J Hernández-Martín; R Pontes; M Díez-Campelo; P Millacoy; P Rodríguez-Otero; F Prosper; J Merino; M B Vidriales; R García-Sanz; A Romero; L Palomera; R Ríos-Tamayo; M Pérez-Andrés; J F Blanco; M González; J J M van Dongen; B Durie; M V Mateos; J San-Miguel; A Orfao
Journal:  Blood Cancer J       Date:  2018-11-19       Impact factor: 11.037

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.